DUBLIN, Iune 26, 2023- Hōʻike "Ka Mākeke Peptide Laau Laau Paʻa - Ka Honua a me ka ʻĀpana ʻĀina: E nānā i nā ʻano Peptide, nā huahana a me ka ʻĀpana ʻĀpana - Ka nānā ʻana a me ka wānana, 2024-2040″.
Ma hope o ka hoʻomaka ʻana o ka mākeke mua loa o ka lāʻau peptide i kaupalena ʻia, ua wānana ʻia ka mākeke lāʻau lapaʻau honua e ulu mai 2024 a 2040. Manaʻo ʻia ka nui o ka mākeke e hiki i $ 60M i 2024 a me $ 17.38B i 2040, me kahi CAGR o 38.94% ma luna. ka manawa wānana 2025-2040.
Manaʻo ʻia ka mākeke lāʻau lapaʻau peptide i hoʻopaʻa ʻia i ka ulu nui i ka wā wānana mai 2025 a 2040, i alakaʻi ʻia i ka hapa nui e ka hoʻohiki ʻana i kahi pipeline peptide i hoʻopaʻa ʻia hou ʻaʻole i kaupalena ʻia i nā mea hoʻokipa.ʻO ka holomua i ka ʻenehana kemika, ka holomua i ka hoʻolaha ʻana o nā peptide synthetic therapeutics i nā makahiki i hala iho nei, a me nā kumukūʻai kūpono i loaʻa i kēia mau biomolecules i nā maʻi like ʻole kekahi mau mea hou e hāpai ana i ka ulu ʻana i ka wā wānana.
Hana ʻia ka nānā ʻana i nā hopena pōkole a lōʻihi ma luna o nā mea e hoʻopilikia nui ai i ka mākeke, ʻo ia hoʻi, nā mea hoʻokele, nā palena a me nā manawa kūpono.Manaʻo ka loiloi wā pōkole i ka manawa 2020-2025 a ʻo ka loiloi wā lōʻihi e noʻonoʻo i ka manawa 2026-2040.
ʻO nā hoʻomohala koʻikoʻi a me nā hoʻolālā i hāpai ʻia e kekahi o nā mea pāʻani koʻikoʻi i kēia mākeke ua hoʻokomo ʻia i ka loiloi loiloi hopena.Eia kekahi, ua loiloi ʻia kēia mau hana koʻikoʻi no ka hoʻomaopopo ʻana i nā manawa e hiki mai ana no ka hoʻohui ʻana i nā ʻenehana holomua e hoʻokō i nā hopena kiʻekiʻe.Eia kekahi, ua noʻonoʻo ʻia ka ʻae ʻana a me ka hoʻokuʻu ʻana o nā ʻoihana a me nā ʻoihana patent i ka wā e loiloi ana i ka dinamika o ka mākeke honua no nā lāʻau peptide i kaupalena ʻia.
ʻO nā kumu koi a me nā mea paʻa ʻO kēia nā kumu koi no ka mākeke Peptide Dependence Inhibitors honua:
4 Nānā Makeke 4.1 Hoʻomaka 4.1.1 Hoʻolālā a me ka Hoʻolālā ʻana o nā Peptides i kaupalena ʻia 4.1.2 Nā ʻano o nā Peptides i kaupalena ʻia 4.2 Evolution o nā Peptides i kaupalena ʻia 4.3 Hoʻomohala ʻana o nā Peptides i kaupalena ʻia e like me nā lāʻau lapaʻau 4.4 Nā ʻāpana Therapeutic Hiki 4.5 ʻOihana Kūʻai Kūʻai 4. ) ) 4.7 Nā ʻano ʻoihana koʻikoʻi ma ke ala o ka hoʻomaka ʻana 4.8 Nā ʻano ʻoihana koʻikoʻi - holomua ʻenehana 4.9 Ka nui o ka mākeke o kēia manawa a me ka ulu ulu ʻana, ʻo ka piliona kālā USD, 2024-2040 a me ka hana hou ʻana no nā hui e hana ana i nā lāʻau peptide i kaupalena ʻia.
5 Nā waiwai o nā peptides i kaupalena ʻia 5.1 Nā ʻano o nā peptides i kaupalena ʻia 5.2 Synthesis o nā peptides i kaupalena ʻia 5.2.1 ʻO nā peptides i kaupalena ʻia 5.2.1 ʻO ka hoʻopaʻa ʻana i nā peptides a me ka hoʻopaʻa ʻana 5.2.2 ʻO ka ligation o nā peptides i nā scaffolds (CLIPS) 5.2.3 ʻO ka hoʻohui ʻana o nā peptide. ʻike (5.2.5 Liquid-Phase Peptide Synthesis (LPPS) 5.2.6 Solid-Phase Peptide Synthesis (SPPS) 5.3 Nā holomua i ka ʻenehana Peptide 5.3.1 Peptide Synthesis me ka hoʻohana ʻana i ka Microfluidics 5.3.2 Solid-Phase Peptide Synthesis me ka hoʻohana ʻana i nā Microwaves 5.4 E koho i ka Pūnaehana
6 ʻIkepili ʻOihana 6.1 Manaʻo nui 6.2 Nā pilikia me nā ala ʻae hoʻoponopono no nā Peptides i kaupalena ʻia 6.3 Nā hiʻohiʻona hoʻoponopono no nā Peptides i kaupalena ʻia 6.4 Nā Koina Hoʻoponopono a me ke kūkulu ʻana o ka US lula 6.5 Nā koi kānāwai a me ka hoʻolālā ʻEulopa 6.5.1 Kaʻina noi laikini EMA 6.5.2 Nā kaʻina hana kikowaena 6.5.3 Nā kaʻina hana i hoʻokaʻawale ʻia 6.5.4 Nā kaʻina hana ʻike like ʻole 6.5.5 Nā kaʻina hana aupuni 6.6 Nā koi kānāwai a me nā papa hana ma Asia-Pacific region 6.6.1 Nā koi kānāwai a me ka hoʻolālā ʻana ma Iapana 6.7 Nā hiʻohiʻona hoʻihoʻi 6.7.1 Nā hiʻohiʻona hoʻihoʻi hou ʻana i ka maʻi autoimmune 6.7.2 Nā hiʻohiʻona hoʻihoʻi maʻi maʻi 6.7.3 Nā hiʻohiʻona hoʻihoʻi maʻi kakaʻikahi
7 Mākeke Dynamics 7.1 Impact Analysis 7.2 Mākeke Kūʻai 7.2.1 Hoʻonui i ka Paʻa Paʻa a me ka Cellular Uptake 7.2.2 Hoʻomohala ʻana i nā Kūlana Synthetic Limited 7.2.3 Nā palena o nā Peptides Kuʻuna 7.2.4 Hoʻonui i ke kālā aupuni a me ka pilikino 7.2.4.1 Ke kālā kālā o nā hui pilikino. .4 .2 Kākoʻo kālā e nā hui i helu ʻia 7.2.4.3 Kākoʻo kālā e nā keʻena aupuni 7.3 Kaohi ʻana o ka mākeke 7.3.1 Hoʻonui i ka hoʻokūkū no nā mea olaola 7.3.2 ʻO ka pilikia o nā hopena immunogenic a me nā waiwai haʻahaʻa o ADME 7.4 Nā manawa kūʻai 7.4.1 Nā peptides i kaupalena ʻia i ka ʻike lāʻau lapaʻau 7.4.2 Nā noi like ʻole ʻōnaehana nerve a me ka maʻi kanesa
8 Nā ʻāina hoʻokūkū 8.1 Nānā o ka ʻāina hoʻokūkū 8.1.1 Nā hana koʻikoʻi 8.1.2 Nā hana hoʻoponopono a me ke kānāwai 8.1.3 Nā hui ʻana a me ka loaʻa ʻana 8.1.4 Nā hana synergy 8.1.5 Nā hana kālā 8.1.6 Hoʻomohala lāʻau lapaʻau.
9 Makeke honua o ka hoʻopaʻa ʻana i nā lāʻau peptide (ma nā kuhikuhi), mln USD, 2024–2040 9.1 Hoʻolālā Hoʻokolohua Clinical no ke kāohi ʻana i nā Peptide Therapies. .2.4 Nonclinical Studies of BT5528 9.1.3 PN-9439.1.3.1 Product Introduction 9.1.3.2 Design study (Phase 2) 9.1.3.3 Efficacy, safety and tolerability data (Phase II) 9.1.4 PN-2359.1.1 Product intro.1.1. 4.2 Hoʻolālā haʻawina (Phase IIb) 9.1.4.3 ʻIkepili pono, palekana a hoʻomanawanui (Phase IIb) 9.1.5 Rusfertide (PTG-300) 9.1.5.1 Nānā huahana 9.1.5.2 Hoʻolālā haʻawina (Phase II) 9.1.5.3 Pono, palekana ʻikepili hiki ke hoʻomanawanui (Phase IIa) 9.1.6 Nā lāʻau lapaʻau Phase III hiki ke kūpono 9.1.7 Zilukoplan (RA101495) 9.1.7.1 Nānā Huahana 9.1.7.2 Hoʻolālā haʻawina (Phase III) 9.1.7.3 ʻIke kūpono, palekana a me ka hoʻomanawanui (Phase III) 9.1. Pharmacokinetic and pharmacodynamic profile of Zilucoplan (Phase I) 9.1.8 Rusfertide (PTG- 300) 9.1.8.1 Nānā huahana 9.1.8.2 Hoʻolālā haʻawina (Phase III) 9.1.8.3 ʻIke pono, palekana a me ka hoʻomanawanui (Phase II) 9.2 hoʻomohala hoʻomohala o ka mākeke honua no nā lāʻau peptide i kaupalena ʻia, USD miliona, 2024-2040 kūleʻa 9.2.2.2 Ke kumu kūʻai o ka hana API (CDMO)
10 Makeke honua no nā lāʻau lapaʻau me ka hana peptide liʻiliʻi (e ke ʻano peptide), US $ mln, 2024-2040 pili peptide (DRP))
11 Makeke honua no nā lāʻau peptide i kaupalena ʻia (e nā huahana hiki ke loaʻa), mln USD, 2024–2040 (RA101495) 11.1.2.1 Hana ʻia API (home) 11.1.2.2 wānana noi API no 2024-2040 11.1.3 11.1.3 Rusfertide (PTG-300) .3.1 Hoʻolaha API (Hoʻopuka) Kūʻai 11.1.4 PN-94311.1.4.1 Hana Hana (Hoʻopuka) 11.1.4.2 Manaʻo Manaʻo API 2024-2040
Ka manawa hoʻouna: Jul-06-2023